Goldman Sachs
MGRX icon

Goldman Sachs’s Mangoceuticals MGRX Stock Holding History

Goldman Sachs’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.23K Buy
+11,757
New +$5.63K ﹤0.01% 6403
2025
Q3 		– Sell
-10,570
Closed -$16.1K – 6539
2025
Q2 		$16.1K Buy
+10,570
New +$19.8K ﹤0.01% 5996
2024
Q4 		– Sell
-679
Closed -$2.4K – 6180
2024
Q3 		$2.4K Buy
+679
New +$3.2K ﹤0.01% 5763

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $488M AUM 14.36% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Goldman Sachs's MGRX Position: Q1 2026 in Review

Goldman Sachs opened a new position in Mangoceuticals (MGRX) in Q1 2026: 11,757 shares worth $4.23K. The stake represents ﹤0.01% of the portfolio and ranks #6403 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in MGRX as recently as Q2 2025.

Goldman Sachs first reported a position in MGRX in Q3 2024 and has held it in 3 quarters since. The position peaked at $16.1K in Q2 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Goldman Sachs held 11,757 shares of Mangoceuticals worth $4.23K as of Q1 2026.
  • Mangoceuticals was a new Goldman Sachs position in Q1 2026.
  • Mangoceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6403 holding.
  • Goldman Sachs first reported a position in Mangoceuticals in Q3 2024 and has held it in 3 quarters since.
  • Goldman Sachs's Mangoceuticals position peaked at $16.1K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.